Over ten-year insulin independence following single allogeneic islet transplant without T-cell depleting antibody induction

Islets. 2018;10(4):168-174. doi: 10.1080/19382014.2018.1451281. Epub 2018 Jul 19.

Abstract

Islet cell transplantation is a promising functional cure for type 1 diabetes; however, maintaining long-term islet graft function and insulin independence is difficult to achieve. In this short report we present a patient with situs inversus, who at the time of islet transplantation had a 26-year history of type 1 diabetes, complicated by hypoglycemic unawareness and severe hypoglycemic events. After a single allogeneic islet transplant of a low islet mass, and despite developing de novo anti-insulin and anti-GAD65 autoantibodies, the patient has remarkably maintained insulin independence with tight glycemic control and normal metabolic profiles for 10 years, after receiving prolonged non-T-cell depleting immunosuppression.

Keywords: T-cell depletion; autoimmunity; immunosuppression; insulin independence; islet transplantation.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 1* / diagnosis
  • Diabetes Mellitus, Type 1* / metabolism
  • Diabetes Mellitus, Type 1* / surgery
  • Female
  • Graft Survival
  • Humans
  • Immunosuppression Therapy* / adverse effects
  • Immunosuppression Therapy* / methods
  • Insulin / blood
  • Islets of Langerhans Transplantation / methods*
  • Monitoring, Physiologic / methods
  • Patient Care Management / methods*
  • Treatment Outcome

Substances

  • Blood Glucose
  • Insulin